This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2025!
March 18-21, 2025San Diego Convention Center

Kathryn Beal
Principal Scientist: Process Development at Pfizer, Inc.


Kathryn Beal is a Principal Scientist in Pfizer’s Cell Line Development group, specializing in the area of molecular biology and CHO expression systems. She earned her bachelor’s degree in Cellular, Molecular and Developmental Biology at the University of New Hampshire (UNH) in 2004. She continued on at UNH and was awarded a teaching assistantship to earn her master’s degree in Genetics in 2006. Kathryn joined Wyeth BioPharma in 2007 in the Cell and Molecular Sciences group. Following the Wyeth/Pfizer merger in 2009, Kathryn continued on in Pfizer’s Cell Line Development group, where she presently works.

Agenda Sessions

  • The impact of expression vector position on transgene transcription allows for rational expression vector design in a targeted integration system